The Latest Breaking News from Colgate

Colgate-Palmolive is scheduled to report its first-quarter results this month, with analysts anticipating a single-digit growth in its bottom line.

These consumer staples stocks could benefit significantly as investors pile into defensive companies.

Consumers who are furious over President Donald Trump’s policies are boycotting U.S. goods - from Coca-Cola to Colgate toothpaste

Colgate-Palmolive has notably underperformed the Dow over the past year and analysts remain cautiously optimistic about the stock’s prospects.

A clear rotation is happening in the market, with money coming out of the discretionary space and into the defensive space as a sign of fear.

Growing concerns over incoming tariffs and inflation are driving heightened uncertainty among U.S. consumers. As a defensive strategy, investors may find value in fundamentally stable consumer staples stocks like Procter & Gamble (PG), Coca-Cola (KO), and Colgate-Palmolive (CL). Continue to read….

I spent months testing products for brighter teeth – here are the ones that impressed us the most

General optimism for the U.S. economy has been disrupted by uncertainty surrounding policy changes, geopolitical tensions, and border crises. Amid this volatility, investing in sound consumer staple stocks Colgate-Palmolive (CL), Chewy (CHWY), and Kimberly-Clark (KMB) could offer investors a reliable path to steady returns. Read more….

Colgate-Palmolive is set to unveil its fourth-quarter results later this month and analysts expect a notable single-digit growth in earnings.

The winds of uncertainty are shaking the foundation of economic optimism. From policy upheavals and global crises to the stubborn creep of inflation, growth prospects appear clouded. In this turbulent landscape, consumer staples, Walmart (WMT), Colgate-Palmolive (CL), and Kimberly-Clark (KMB), could provide a shield against market volatility. Continue to read….

Despite Colgate-Palmolive’s underperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.